Drug Development Pipeline
Restore CFTR Function
ABBV-3067 is a type of CFTR modulator called a potentiator. Potentiators help facilitate the opening of the chloride channel on the cell surface to allow chloride and sodium (salt) to move in and out of the cell.
A phase 2 study to test the safety and effectiveness of ABBV-3067 is underway. The study will test ABBV-3067 both alone and in combination with ABBV-2222, a CFTR corrector.
This program is sponsored by Abbvie and is being conducted within the Therapeutics Development Network.
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.Learn More